[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$facFuAUjfB2eshCWERl5ELTtgIa5MurXxyJNUP6e00gE":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":61,"rows":68},"National Institute of Dental and Craniofacial Research (NIDCR)",[4],94,false,13,3,34779,4,55,[14,17,20,23,26,29,31,33],{"name":15,"count":16},"Healthy",15,{"name":18,"count":19},"Sjogren's Syndrome",14,{"name":21,"count":22},"Pain",10,{"name":24,"count":25},"Xerostomia",6,{"name":27,"count":28},"Polyostotic Fibrous Dysplasia",5,{"name":30,"count":11},"Tooth Extraction",{"name":32,"count":11},"Salivary Gland Disease",{"name":34,"count":9},"Dental Caries",[36,41,46,51,56],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT03571191","Denosumab Treatment for Fibrous Dysplasia","2021-11-17","Denosumab",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT04496960","Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome","2025-01-14","tofacitinib",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT00804154","Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer","2027-02-07","Intrathecal Resiniferatoxin",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT07541209","Safety and Efficacy of PTH-IA","2029-06-01","PTH-IA",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT07281456","Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease","2030-12-15","Tofacitinib",[62,63,64,65,66,67],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[69,100,134,155,177,201,226,244,272,316,351,390,415,444,467,488,515,533,556,574,598,622,647,672,696,719,745,768,793,815,839,862,887,914,932,975],{"intervention":60,"totalTrials":70,"cells":71},2,{"EARLY_PHASE1":72,"PHASE1":75,"PHASE2":77,"PHASE3":94,"PHASE4":96,"NA":98},{"trials":73,"activeCount":74},[],0,{"trials":76,"activeCount":74},[],{"trials":78,"activeCount":70,"soonestReadout":44},[79,86],{"nctId":57,"briefTitle":58,"status":80,"phases":81,"primaryCompletion":59,"completion":59,"start":82,"enrollment":83,"conditions":84,"interventions":85},"RECRUITING",[64],"2025-12-18",60,[18],[60],{"nctId":42,"briefTitle":43,"status":87,"phases":88,"primaryCompletion":44,"completion":89,"start":90,"enrollment":91,"conditions":92,"interventions":93},"ACTIVE_NOT_RECRUITING",[63,64],"2026-09-22","2021-05-18",23,[18],[45],{"trials":95,"activeCount":74},[],{"trials":97,"activeCount":74},[],{"trials":99,"activeCount":74},[],{"intervention":40,"totalTrials":70,"cells":101},{"EARLY_PHASE1":102,"PHASE1":104,"PHASE2":106,"PHASE3":128,"PHASE4":130,"NA":132},{"trials":103,"activeCount":74},[],{"trials":105,"activeCount":74},[],{"trials":107,"activeCount":127,"soonestReadout":39},[108,116],{"nctId":37,"briefTitle":38,"status":87,"phases":109,"primaryCompletion":39,"completion":110,"start":111,"enrollment":112,"conditions":113,"interventions":115},[64],"2030-03-15","2019-06-13",9,[114,21],"Bone Diseases",[40],{"nctId":117,"briefTitle":118,"status":119,"phases":120,"primaryCompletion":121,"completion":121,"start":122,"enrollment":16,"conditions":123,"interventions":125},"NCT05419050","Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia","COMPLETED",[64],"2026-01-09","2022-10-12",[124],"Fibrous Dysplasia",[126],"denosumab",1,{"trials":129,"activeCount":74},[],{"trials":131,"activeCount":74},[],{"trials":133,"activeCount":74},[],{"intervention":55,"totalTrials":127,"cells":135},{"EARLY_PHASE1":136,"PHASE1":138,"PHASE2":140,"PHASE3":149,"PHASE4":151,"NA":153},{"trials":137,"activeCount":74},[],{"trials":139,"activeCount":74},[],{"trials":141,"activeCount":127,"soonestReadout":54},[142],{"nctId":52,"briefTitle":53,"status":80,"phases":143,"primaryCompletion":54,"completion":54,"start":144,"enrollment":145,"conditions":146,"interventions":148},[63,64],"2026-05-27",12,[147],"Jansen's Metaphyseal Chondrodysplasia",[55],{"trials":150,"activeCount":74},[],{"trials":152,"activeCount":74},[],{"trials":154,"activeCount":74},[],{"intervention":50,"totalTrials":127,"cells":156},{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":169,"PHASE3":171,"PHASE4":173,"NA":175},{"trials":158,"activeCount":74},[],{"trials":160,"activeCount":127,"soonestReadout":49},[161],{"nctId":47,"briefTitle":48,"status":80,"phases":162,"primaryCompletion":49,"completion":49,"start":163,"enrollment":164,"conditions":165,"interventions":168},[63],"2009-08-14",45,[166,167],"Intractable Pain","Palliative Care",[50],{"trials":170,"activeCount":74},[],{"trials":172,"activeCount":74},[],{"trials":174,"activeCount":74},[],{"trials":176,"activeCount":74},[],{"intervention":178,"totalTrials":127,"cells":179},"Pegvisomant",{"EARLY_PHASE1":180,"PHASE1":182,"PHASE2":184,"PHASE3":186,"PHASE4":197,"NA":199},{"trials":181,"activeCount":74},[],{"trials":183,"activeCount":74},[],{"trials":185,"activeCount":74},[],{"trials":187,"activeCount":74},[188],{"nctId":189,"briefTitle":190,"status":119,"phases":191,"completion":192,"start":193,"enrollment":22,"conditions":194,"interventions":196},"NCT00017927","A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome",[65],"2005-06","2001-06",[195,27],"McCune Albright Syndrome",[178],{"trials":198,"activeCount":74},[],{"trials":200,"activeCount":74},[],{"intervention":202,"totalTrials":127,"cells":203},"conjugated estrogens",{"EARLY_PHASE1":204,"PHASE1":206,"PHASE2":208,"PHASE3":210,"PHASE4":222,"NA":224},{"trials":205,"activeCount":74},[],{"trials":207,"activeCount":74},[],{"trials":209,"activeCount":74},[],{"trials":211,"activeCount":74},[212],{"nctId":213,"briefTitle":214,"status":119,"phases":215,"start":216,"enrollment":217,"conditions":218,"interventions":220},"NCT00004650","Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss",[65],"1993-08",150,[219],"Osteoporosis",[202,221],"Medroxyprogesterone",{"trials":223,"activeCount":74},[],{"trials":225,"activeCount":74},[],{"intervention":221,"totalTrials":127,"cells":227},{"EARLY_PHASE1":228,"PHASE1":230,"PHASE2":232,"PHASE3":234,"PHASE4":240,"NA":242},{"trials":229,"activeCount":74},[],{"trials":231,"activeCount":74},[],{"trials":233,"activeCount":74},[],{"trials":235,"activeCount":74},[236],{"nctId":213,"briefTitle":214,"status":119,"phases":237,"start":216,"enrollment":217,"conditions":238,"interventions":239},[65],[219],[202,221],{"trials":241,"activeCount":74},[],{"trials":243,"activeCount":74},[],{"intervention":245,"totalTrials":127,"cells":246},"PTH 1-34",{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":253,"PHASE4":268,"NA":270},{"trials":248,"activeCount":74},[],{"trials":250,"activeCount":74},[],{"trials":252,"activeCount":74},[],{"trials":254,"activeCount":74},[255],{"nctId":256,"briefTitle":257,"status":258,"phases":259,"primaryCompletion":260,"completion":261,"start":262,"enrollment":263,"conditions":264,"interventions":267},"NCT00395538","Effects of PTH Replacement on Bone in Hypoparathyroidism","TERMINATED",[65],"2017-09-30","2017-10-04","2006-10-30",46,[265,266],"Hypoparathyroidism","DiGeorge Syndrome",[245],{"trials":269,"activeCount":74},[],{"trials":271,"activeCount":74},[],{"intervention":273,"totalTrials":9,"cells":274},"Etanercept",{"EARLY_PHASE1":275,"PHASE1":277,"PHASE2":279,"PHASE3":310,"PHASE4":312,"NA":314},{"trials":276,"activeCount":74},[],{"trials":278,"activeCount":74},[],{"trials":280,"activeCount":74},[281,290,299],{"nctId":282,"briefTitle":283,"status":119,"phases":284,"completion":285,"start":286,"enrollment":287,"conditions":288,"interventions":289},"NCT00001954","Etanercept Therapy for Sjogren's Syndrome",[64],"2003-11","1999-12",28,[18],[273],{"nctId":291,"briefTitle":292,"status":119,"phases":293,"completion":294,"start":286,"enrollment":217,"conditions":295,"interventions":297},"NCT00001955","Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)",[64],"2004-02",[296],"Temporomandibular Joint Disorder",[273,298],"Celecoxib",{"nctId":300,"briefTitle":301,"status":119,"phases":302,"completion":303,"start":304,"enrollment":305,"conditions":306,"interventions":308},"NCT00006070","Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction",[64],"2004-05","2000-07",86,[15,307],"Inflammation",[309],"etanercept",{"trials":311,"activeCount":74},[],{"trials":313,"activeCount":74},[],{"trials":315,"activeCount":74},[],{"intervention":317,"totalTrials":70,"cells":318},"Thalidomide",{"EARLY_PHASE1":319,"PHASE1":321,"PHASE2":323,"PHASE3":345,"PHASE4":347,"NA":349},{"trials":320,"activeCount":74},[],{"trials":322,"activeCount":74},[],{"trials":324,"activeCount":74},[325,333],{"nctId":326,"briefTitle":327,"status":119,"phases":328,"completion":329,"start":330,"enrollment":287,"conditions":331,"interventions":332},"NCT00001599","Pilot Study of Thalidomide to Treat Sjogren's Syndrome",[64],"2002-06","1997-05",[18,24],[317],{"nctId":334,"briefTitle":335,"status":119,"phases":336,"completion":337,"start":338,"enrollment":339,"conditions":340,"interventions":344},"NCT00001524","Thalidomide to Treat Oral Lesions in HIV-Infected Patients",[64],"2004-12","1996-06",110,[341,342,343],"Acquired Immunodeficiency Syndrome","Burning Mouth Syndrome","HIV Infection",[317],{"trials":346,"activeCount":74},[],{"trials":348,"activeCount":74},[],{"trials":350,"activeCount":74},[],{"intervention":352,"totalTrials":70,"cells":353},"Dextromethorphan",{"EARLY_PHASE1":354,"PHASE1":356,"PHASE2":358,"PHASE3":384,"PHASE4":386,"NA":388},{"trials":355,"activeCount":74},[],{"trials":357,"activeCount":74},[],{"trials":359,"activeCount":74},[360,371],{"nctId":361,"briefTitle":362,"status":119,"phases":363,"completion":364,"start":365,"enrollment":366,"conditions":367,"interventions":370},"NCT00001725","Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain",[64],"2002-01","1997-12",100,[368,21,369],"Facial Neuralgia","Trigeminal Neuralgia",[352],{"nctId":372,"briefTitle":373,"status":119,"phases":374,"completion":375,"start":376,"enrollment":377,"conditions":378,"interventions":382},"NCT00001344","Dextromethorphan Versus Placebo for Neuropathic Pain",[64],"2001-02","1993-03",129,[379,380,381],"Diabetic Neuropathies","Herpes Zoster","Neuralgia",[383],"dextromethorphan",{"trials":385,"activeCount":74},[],{"trials":387,"activeCount":74},[],{"trials":389,"activeCount":74},[],{"intervention":391,"totalTrials":127,"cells":392},"dexamethasone 0.01% solution",{"EARLY_PHASE1":393,"PHASE1":395,"PHASE2":397,"PHASE3":409,"PHASE4":411,"NA":413},{"trials":394,"activeCount":74},[],{"trials":396,"activeCount":74},[],{"trials":398,"activeCount":74},[399],{"nctId":400,"briefTitle":401,"status":119,"phases":402,"completion":403,"start":404,"enrollment":405,"conditions":406,"interventions":408},"NCT00111072","Dexamethasone to Treat Oral Lichen Planus",[64],"2006-03","2005-05",70,[407],"Oral Lichen Planus",[391],{"trials":410,"activeCount":74},[],{"trials":412,"activeCount":74},[],{"trials":414,"activeCount":74},[],{"intervention":416,"totalTrials":127,"cells":417},"Sirolimus",{"EARLY_PHASE1":418,"PHASE1":420,"PHASE2":422,"PHASE3":438,"PHASE4":440,"NA":442},{"trials":419,"activeCount":74},[],{"trials":421,"activeCount":74},[],{"trials":423,"activeCount":74},[424],{"nctId":425,"briefTitle":426,"status":119,"phases":427,"primaryCompletion":428,"completion":429,"start":430,"enrollment":431,"conditions":432,"interventions":437},"NCT01195922","Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma",[63,64],"2015-06","2015-12","2010-08",37,[433,434,435,436],"Mouth Neoplasms","Head and Neck Neoplasms","Tongue Neoplasms","Carcinoma, Squamous Cell",[416],{"trials":439,"activeCount":74},[],{"trials":441,"activeCount":74},[],{"trials":443,"activeCount":74},[],{"intervention":445,"totalTrials":127,"cells":446},"Flurbiprofen",{"EARLY_PHASE1":447,"PHASE1":449,"PHASE2":451,"PHASE3":461,"PHASE4":463,"NA":465},{"trials":448,"activeCount":74},[],{"trials":450,"activeCount":74},[],{"trials":452,"activeCount":74},[453],{"nctId":454,"briefTitle":455,"status":119,"phases":456,"completion":457,"start":458,"enrollment":366,"conditions":459,"interventions":460},"NCT00001724","Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction",[64],"2001-11","1997-11",[21],[445],{"trials":462,"activeCount":74},[],{"trials":464,"activeCount":74},[],{"trials":466,"activeCount":74},[],{"intervention":468,"totalTrials":127,"cells":469},"Rofecoxib",{"EARLY_PHASE1":470,"PHASE1":472,"PHASE2":474,"PHASE3":482,"PHASE4":484,"NA":486},{"trials":471,"activeCount":74},[],{"trials":473,"activeCount":74},[],{"trials":475,"activeCount":74},[476],{"nctId":477,"briefTitle":478,"status":119,"phases":479,"completion":285,"start":457,"enrollment":217,"conditions":480,"interventions":481},"NCT00026819","Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction",[64],[21],[468],{"trials":483,"activeCount":74},[],{"trials":485,"activeCount":74},[],{"trials":487,"activeCount":74},[],{"intervention":489,"totalTrials":127,"cells":490},"Nortriptyline",{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":509,"PHASE4":511,"NA":513},{"trials":492,"activeCount":74},[],{"trials":494,"activeCount":74},[],{"trials":496,"activeCount":74},[497],{"nctId":498,"briefTitle":499,"status":119,"phases":500,"completion":501,"start":502,"enrollment":503,"conditions":504,"interventions":507},"NCT00009672","Pain Treatment for Sciatica",[64],"2006-12-12","2001-01-30",80,[505,506],"Radiculopathy","Sciatica",[489,508],"Morphine",{"trials":510,"activeCount":74},[],{"trials":512,"activeCount":74},[],{"trials":514,"activeCount":74},[],{"intervention":508,"totalTrials":127,"cells":516},{"EARLY_PHASE1":517,"PHASE1":519,"PHASE2":521,"PHASE3":527,"PHASE4":529,"NA":531},{"trials":518,"activeCount":74},[],{"trials":520,"activeCount":74},[],{"trials":522,"activeCount":74},[523],{"nctId":498,"briefTitle":499,"status":119,"phases":524,"completion":501,"start":502,"enrollment":503,"conditions":525,"interventions":526},[64],[505,506],[489,508],{"trials":528,"activeCount":74},[],{"trials":530,"activeCount":74},[],{"trials":532,"activeCount":74},[],{"intervention":534,"totalTrials":127,"cells":535},"Topiramate",{"EARLY_PHASE1":536,"PHASE1":538,"PHASE2":540,"PHASE3":550,"PHASE4":552,"NA":554},{"trials":537,"activeCount":74},[],{"trials":539,"activeCount":74},[],{"trials":541,"activeCount":74},[542],{"nctId":543,"briefTitle":544,"status":119,"phases":545,"completion":546,"start":375,"enrollment":547,"conditions":548,"interventions":549},"NCT00011804","Topiramate in the Treatment of Sciatica",[64],"2005-02",65,[506],[534],{"trials":551,"activeCount":74},[],{"trials":553,"activeCount":74},[],{"trials":555,"activeCount":74},[],{"intervention":298,"totalTrials":127,"cells":557},{"EARLY_PHASE1":558,"PHASE1":560,"PHASE2":562,"PHASE3":568,"PHASE4":570,"NA":572},{"trials":559,"activeCount":74},[],{"trials":561,"activeCount":74},[],{"trials":563,"activeCount":74},[564],{"nctId":291,"briefTitle":292,"status":119,"phases":565,"completion":294,"start":286,"enrollment":217,"conditions":566,"interventions":567},[64],[296],[273,298],{"trials":569,"activeCount":74},[],{"trials":571,"activeCount":74},[],{"trials":573,"activeCount":74},[],{"intervention":575,"totalTrials":127,"cells":576},"Dexamethasone Parotid Irrigation",{"EARLY_PHASE1":577,"PHASE1":579,"PHASE2":581,"PHASE3":592,"PHASE4":594,"NA":596},{"trials":578,"activeCount":74},[],{"trials":580,"activeCount":74},[],{"trials":582,"activeCount":74},[583],{"nctId":584,"briefTitle":585,"status":258,"phases":586,"primaryCompletion":587,"completion":587,"start":588,"enrollment":19,"conditions":589,"interventions":591},"NCT01316770","Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects",[64],"2017-04-17","2011-05-01",[590,24],"Sjögren's Syndrome",[575],{"trials":593,"activeCount":74},[],{"trials":595,"activeCount":74},[],{"trials":597,"activeCount":74},[],{"intervention":599,"totalTrials":127,"cells":600},"Burosumab",{"EARLY_PHASE1":601,"PHASE1":603,"PHASE2":605,"PHASE3":616,"PHASE4":618,"NA":620},{"trials":602,"activeCount":74},[],{"trials":604,"activeCount":74},[],{"trials":606,"activeCount":74},[607],{"nctId":608,"briefTitle":609,"status":119,"phases":610,"primaryCompletion":611,"completion":611,"start":612,"enrollment":145,"conditions":613,"interventions":615},"NCT05509595","Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia",[64],"2024-11-18","2022-12-07",[614],"Fibrous Dysplasia Of Bone",[599],{"trials":617,"activeCount":74},[],{"trials":619,"activeCount":74},[],{"trials":621,"activeCount":74},[],{"intervention":623,"totalTrials":127,"cells":624},"encaleret",{"EARLY_PHASE1":625,"PHASE1":627,"PHASE2":629,"PHASE3":641,"PHASE4":643,"NA":645},{"trials":626,"activeCount":74},[],{"trials":628,"activeCount":74},[],{"trials":630,"activeCount":74},[631],{"nctId":632,"briefTitle":633,"status":119,"phases":634,"primaryCompletion":635,"completion":636,"start":637,"enrollment":8,"conditions":638,"interventions":640},"NCT05735015","PTH-independent Effects of Encaleret",[64],"2025-05-21","2025-08-12","2023-09-01",[639],"Post-Surgical Hypoparathyroidism",[623],{"trials":642,"activeCount":74},[],{"trials":644,"activeCount":74},[],{"trials":646,"activeCount":74},[],{"intervention":648,"totalTrials":127,"cells":649},"Fosamax",{"EARLY_PHASE1":650,"PHASE1":652,"PHASE2":654,"PHASE3":666,"PHASE4":668,"NA":670},{"trials":651,"activeCount":74},[],{"trials":653,"activeCount":74},[],{"trials":655,"activeCount":74},[656],{"nctId":657,"briefTitle":658,"status":119,"phases":659,"primaryCompletion":660,"completion":661,"start":662,"enrollment":663,"conditions":664,"interventions":665},"NCT00001728","Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome",[64],"2007-08-19","2011-05-02","1998-08-24",40,[27],[648],{"trials":667,"activeCount":74},[],{"trials":669,"activeCount":74},[],{"trials":671,"activeCount":74},[],{"intervention":673,"totalTrials":127,"cells":674},"Rofecoxib and Bupivacaine",{"EARLY_PHASE1":675,"PHASE1":677,"PHASE2":679,"PHASE3":690,"PHASE4":692,"NA":694},{"trials":676,"activeCount":74},[],{"trials":678,"activeCount":74},[],{"trials":680,"activeCount":74},[681],{"nctId":682,"briefTitle":683,"status":119,"phases":684,"completion":685,"start":686,"enrollment":687,"conditions":688,"interventions":689},"NCT00050362","Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction",[64],"2004-10","2002-12",136,[21,30],[673],{"trials":691,"activeCount":74},[],{"trials":693,"activeCount":74},[],{"trials":695,"activeCount":74},[],{"intervention":697,"totalTrials":127,"cells":698},"Raptiva",{"EARLY_PHASE1":699,"PHASE1":701,"PHASE2":703,"PHASE3":713,"PHASE4":715,"NA":717},{"trials":700,"activeCount":74},[],{"trials":702,"activeCount":74},[],{"trials":704,"activeCount":74},[705],{"nctId":706,"briefTitle":707,"status":258,"phases":708,"primaryCompletion":709,"completion":709,"start":710,"enrollment":22,"conditions":711,"interventions":712},"NCT00344448","Pilot Study of Raptiva to Treat Sjogren's Syndrome",[64],"2009-01","2006-06",[18],[697],{"trials":714,"activeCount":74},[],{"trials":716,"activeCount":74},[],{"trials":718,"activeCount":74},[],{"intervention":720,"totalTrials":127,"cells":721},"BGJ398",{"EARLY_PHASE1":722,"PHASE1":724,"PHASE2":726,"PHASE3":739,"PHASE4":741,"NA":743},{"trials":723,"activeCount":74},[],{"trials":725,"activeCount":74},[],{"trials":727,"activeCount":74},[728],{"nctId":729,"briefTitle":730,"status":258,"phases":731,"primaryCompletion":732,"completion":733,"start":734,"enrollment":11,"conditions":735,"interventions":738},"NCT03510455","BGJ398 for the Treatment of Tumor-Induced Osteomalacia",[64],"2020-02-28","2020-05-04","2019-02-27",[736,737],"Tumor-Induced Osteomalacia","Oncogenic Osteomalacia",[720],{"trials":740,"activeCount":74},[],{"trials":742,"activeCount":74},[],{"trials":744,"activeCount":74},[],{"intervention":746,"totalTrials":127,"cells":747},"Celebrex",{"EARLY_PHASE1":748,"PHASE1":750,"PHASE2":752,"PHASE3":762,"PHASE4":764,"NA":766},{"trials":749,"activeCount":74},[],{"trials":751,"activeCount":74},[],{"trials":753,"activeCount":74},[754],{"nctId":755,"briefTitle":756,"status":119,"phases":757,"completion":294,"start":286,"enrollment":758,"conditions":759,"interventions":761},"NCT00006299","Celebrex for Pain Relief After Oral Surgery",[64],120,[760],"Facial Pain",[746],{"trials":763,"activeCount":74},[],{"trials":765,"activeCount":74},[],{"trials":767,"activeCount":74},[],{"intervention":769,"totalTrials":127,"cells":770},"Hydroxychloroquine",{"EARLY_PHASE1":771,"PHASE1":773,"PHASE2":775,"PHASE3":787,"PHASE4":789,"NA":791},{"trials":772,"activeCount":74},[],{"trials":774,"activeCount":74},[],{"trials":776,"activeCount":74},[777],{"nctId":778,"briefTitle":779,"status":119,"phases":780,"completion":781,"start":782,"enrollment":783,"conditions":784,"interventions":786},"NCT00102557","Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus",[64],"2005-10","2005-01",74,[785],"Lichen Planus, Oral",[769],{"trials":788,"activeCount":74},[],{"trials":790,"activeCount":74},[],{"trials":792,"activeCount":74},[],{"intervention":794,"totalTrials":127,"cells":795},"Dehydroepiandrosterone",{"EARLY_PHASE1":796,"PHASE1":798,"PHASE2":800,"PHASE3":809,"PHASE4":811,"NA":813},{"trials":797,"activeCount":74},[],{"trials":799,"activeCount":74},[],{"trials":801,"activeCount":74},[802],{"nctId":803,"briefTitle":804,"status":119,"phases":805,"completion":329,"start":330,"enrollment":287,"conditions":806,"interventions":808},"NCT00001598","DHEA Treatment for Sjogren's Syndrome",[64],[807,32,18,24],"Lacrimal Apparatus Disease",[794],{"trials":810,"activeCount":74},[],{"trials":812,"activeCount":74},[],{"trials":814,"activeCount":74},[],{"intervention":816,"totalTrials":127,"cells":817},"SLPI",{"EARLY_PHASE1":818,"PHASE1":820,"PHASE2":831,"PHASE3":833,"PHASE4":835,"NA":837},{"trials":819,"activeCount":74},[],{"trials":821,"activeCount":74},[822],{"nctId":823,"briefTitle":824,"status":119,"phases":825,"completion":826,"start":827,"enrollment":83,"conditions":828,"interventions":830},"NCT00005569","Effects of Topical SLPI on Skin Wounds",[63],"2003-07","2000-04",[15,829],"Wound Healing",[816],{"trials":832,"activeCount":74},[],{"trials":834,"activeCount":74},[],{"trials":836,"activeCount":74},[],{"trials":838,"activeCount":74},[],{"intervention":840,"totalTrials":127,"cells":841},"Osteomalacia",{"EARLY_PHASE1":842,"PHASE1":844,"PHASE2":854,"PHASE3":856,"PHASE4":858,"NA":860},{"trials":843,"activeCount":74},[],{"trials":845,"activeCount":74},[846],{"nctId":847,"briefTitle":848,"status":258,"phases":849,"primaryCompletion":850,"completion":850,"start":851,"enrollment":127,"conditions":852,"interventions":853},"NCT01748812","Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)",[63],"2016-12-31","2012-11-16",[840],[840],{"trials":855,"activeCount":74},[],{"trials":857,"activeCount":74},[],{"trials":859,"activeCount":74},[],{"trials":861,"activeCount":74},[],{"intervention":863,"totalTrials":127,"cells":864},"Letrozole",{"EARLY_PHASE1":865,"PHASE1":867,"PHASE2":879,"PHASE3":881,"PHASE4":883,"NA":885},{"trials":866,"activeCount":74},[],{"trials":868,"activeCount":74},[869],{"nctId":870,"briefTitle":871,"status":119,"phases":872,"completion":873,"start":874,"enrollment":875,"conditions":876,"interventions":878},"NCT00006174","Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome",[63],"2009-05-18","2000-08-03",25,[195,27,877],"Precocious Puberty",[863],{"trials":880,"activeCount":74},[],{"trials":882,"activeCount":74},[],{"trials":884,"activeCount":74},[],{"trials":886,"activeCount":74},[],{"intervention":888,"totalTrials":127,"cells":889},"Gene Transfer",{"EARLY_PHASE1":890,"PHASE1":892,"PHASE2":906,"PHASE3":908,"PHASE4":910,"NA":912},{"trials":891,"activeCount":74},[],{"trials":893,"activeCount":74},[894],{"nctId":895,"briefTitle":896,"status":119,"phases":897,"primaryCompletion":898,"completion":899,"start":900,"enrollment":901,"conditions":902,"interventions":904},"NCT00372320","Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer",[63],"2014-03-19","2018-09-05","2006-09-01",17,[903],"Parotid Salivary Dysfunction",[888,905],"AdhAQP1",{"trials":907,"activeCount":74},[],{"trials":909,"activeCount":74},[],{"trials":911,"activeCount":74},[],{"trials":913,"activeCount":74},[],{"intervention":905,"totalTrials":127,"cells":915},{"EARLY_PHASE1":916,"PHASE1":918,"PHASE2":924,"PHASE3":926,"PHASE4":928,"NA":930},{"trials":917,"activeCount":74},[],{"trials":919,"activeCount":74},[920],{"nctId":895,"briefTitle":896,"status":119,"phases":921,"primaryCompletion":898,"completion":899,"start":900,"enrollment":901,"conditions":922,"interventions":923},[63],[903],[888,905],{"trials":925,"activeCount":74},[],{"trials":927,"activeCount":74},[],{"trials":929,"activeCount":74},[],{"trials":931,"activeCount":74},[],{"intervention":933,"totalTrials":9,"cells":934},"Capsaicin",{"EARLY_PHASE1":935,"PHASE1":937,"PHASE2":939,"PHASE3":957,"PHASE4":959,"NA":961},{"trials":936,"activeCount":74},[],{"trials":938,"activeCount":74},[],{"trials":940,"activeCount":74},[941,949],{"nctId":942,"briefTitle":943,"status":119,"phases":944,"completion":781,"start":945,"enrollment":946,"conditions":947,"interventions":948},"NCT00088686","Capsaicin to Control Pain Following Third Molar Extraction",[64],"2004-07",75,[15,30],[933],{"nctId":950,"briefTitle":943,"status":119,"phases":951,"completion":952,"start":953,"enrollment":954,"conditions":955,"interventions":956},"NCT00008476",[64],"2004-01","2001-01",162,[760],[933],{"trials":958,"activeCount":74},[],{"trials":960,"activeCount":74},[],{"trials":962,"activeCount":74},[963],{"nctId":964,"briefTitle":965,"status":119,"phases":966,"completion":967,"start":968,"enrollment":969,"conditions":970,"interventions":973},"NCT00001307","Positron Emission Tomography to Measure Pain and Pain Control",[],"2005-08","1992-08",273,[15,971,21,972],"Hyperalgesia","Peripheral Nervous System Disease",[974,933],"Oxygen-15 Water",{"intervention":974,"totalTrials":127,"cells":976},{"EARLY_PHASE1":977,"PHASE1":979,"PHASE2":981,"PHASE3":983,"PHASE4":985,"NA":987},{"trials":978,"activeCount":74},[],{"trials":980,"activeCount":74},[],{"trials":982,"activeCount":74},[],{"trials":984,"activeCount":74},[],{"trials":986,"activeCount":74},[],{"trials":988,"activeCount":74},[989],{"nctId":964,"briefTitle":965,"status":119,"phases":990,"completion":967,"start":968,"enrollment":969,"conditions":991,"interventions":992},[],[15,971,21,972],[974,933]]